In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of the Certificate received from Kfintech Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th September 2021.
The above information is a part of company’s filings submitted to BSE.